Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis

Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis

(2015) Mika Komori et al.   ANNALS OF NEUROLOGY

Probing the extracellular diffusion of antibodies in brain using in vivo integrative optical imaging and ex vivo fluorescence imaging

(2015) Daniel J. Wolak et al.   JOURNAL OF CONTROLLED RELEASE

Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases

(2014) S. Han et al.   JOURNAL OF IMMUNOLOGY

A Complex Role of Herpes Viruses in the Disease Process of Multiple Sclerosis

(2014) Simone C. Wuest et al.   PLoS One

Neuronal Surface Antibody-Mediated Autoimmune Encephalitis

(2014) Jenny Linnoila et al.   SEMINARS IN NEUROLOGY

Neurofilaments as biomarkers in multiple sclerosis

(2012) Charlotte E Teunissen et al.   Multiple Sclerosis Journal

Will the real multiple sclerosis please stand up?

(2012) Peter K. Stys et al.   NATURE REVIEWS NEUROSCIENCE

Chemokine/cytokine profiling after rituximab: Reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS

(2011) Michael R. Pranzatelli et al.   CYTOKINE

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY

The relation between inflammation and neurodegeneration in multiple sclerosis brains

(2009) Josa M. Frischer et al.   BRAIN

A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma

(2008) E. Racila et al.   CLINICAL CANCER RESEARCH

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL

(2008) A. Klepfish et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE